InvestorsHub Logo

longfellow95

01/16/19 11:10 PM

#208721 RE: biosectinvestor #208716

Hi Bio.
Well, that would be advantage BP again then.
A terrible shame.

And even worse if patient advocacy groups are effectively denied news about promising pipeline treatments.

The AF/Rattan rule (or whatever it is called), is only a truism because the entire deck appears stacked against the microcaps.

CogDiss 1188X

01/17/19 2:18 AM

#208735 RE: biosectinvestor #208716

Any thoughts on “that damn publication?”